Analyst firms · Piper Sandler · HCAT
Piper Sandler HCAT price target and rating history
Health Catalyst Inc (HCAT) · Technology
Piper Sandler rates Health Catalyst Inc (HCAT) Neutral with a $4 price target, as of its latest action on Aug 27, 2025. It has published 4 rating actions on HCAT since March 2022, including 1 upgrade and 2 downgrades.
- Current rating
- Neutral
- Price target
- $4
- Median target, all firms
- Too few
- Actions on HCAT
- 4
Piper Sandler price target on HCAT
Every Piper Sandler rating on HCAT
- Aug 27, 2025
- Nov 13, 2023
- Sep 13, 2022
- Mar 7, 2022
How other firms rate HCAT
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Canaccord Genuity | Hold | $1.80 | Aug 21, 2026 |
| Wells Fargo | Equal Weight | $1 | Mar 18, 2026 |
Questions about Piper Sandler and HCAT
- What is Piper Sandler's price target for HCAT?
- Piper Sandler's latest stated price target for Health Catalyst Inc (HCAT) is $4, from its action on Aug 27, 2025.
- What is Piper Sandler's rating on HCAT?
- Piper Sandler rates HCAT Neutral, a neutral rating, as of Aug 27, 2025.
- When did Piper Sandler last change its view on HCAT?
- On Aug 27, 2025, Piper Sandler downgrades to Neutral from Overweight, price target $4.
More HCAT rating histories
All Piper Sandler ratingsHCAT news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.